目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Application
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Application outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Preclinical Imaging Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Preclinical Imaging Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape

Chapter 4. Preclinical Imaging Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Preclinical Imaging Type Market Movement Analysis
4.3. Global Preclinical Imaging Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
4.4. Modality
4.4.1. Modality market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2. Optical Imaging (BLI & F)
4.4.2.1. Optical Imaging (BLI & F) market estimates and forecasts 2021 to 2033 (USD Million)
4.4.3. Magnetic Resonance Imaging (MRI)
4.4.3.1. Magnetic Resonance Imaging (MRI) market estimates and forecasts 2021 to 2033 (USD Million)
4.4.4. Positron Emission Tomography (PET)
4.4.4.1. Positron Emission Tomography (PET) market estimates and forecasts 2021 to 2033 (USD Million)
4.4.5. Single Photon Emission Computed Tomography (SPECT)
4.4.5.1. Single Photon Emission Computed Tomography (SPECT) market estimates and forecasts 2021 to 2033 (USD Million)
4.4.6. Computed Tomography (CT)
4.4.6.1. Computed Tomography (CT) market estimates and forecasts 2021 to 2033 (USD Million)
4.4.7. Ultrasound Imaging (US)
4.4.7.1. Ultrasound Imaging (US) market estimates and forecasts 2021 to 2033 (USD Million)
4.4.8. Photoacoustic Imaging (PAI)
4.4.8.1. Photoacoustic Imaging (PAI) market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9. Hybrid Imaging Systems
4.4.9.1. Hybrid Imaging Systems market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.2. Bi-Modal
4.4.9.2.1. Bi-Modal market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.2.2. SPECT-CT
4.4.9.2.2.1. SPECT-CT market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.2.3. PET-CT
4.4.9.2.3.1. PET-CT market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.2.4. SPECT-PET
4.4.9.2.4.1. SPECT-PET market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.2.5. PET-MRI
4.4.9.2.5.1. PET-MRI market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.2.6. Optical-CT
4.4.9.2.6.1. Optical-CT market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.2.7. Others
4.4.9.2.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.3. Tri-Modal
4.4.9.3.1. Tri-Modal market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.3.2. PET-SPECT-CT
4.4.9.3.2.1. PET-SPECT-CT market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.3.3. PET-SPECT-MRI
4.4.9.3.3.1. PET-SPECT-MRI market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.3.4. PET-CT-Optical
4.4.9.3.4.1. PET-CT-Optical market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.3.5. Others
4.4.9.3.5.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
4.4.10. Others
4.4.10.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Reagent
4.5.1. Reagent market estimates and forecasts 2021 to 2033 (USD Million)
4.6. Service
4.6.1. Service market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Preclinical Imaging Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Preclinical Imaging Application Market Movement Analysis
5.3. Global Preclinical Imaging Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Drug Discovery & Development
5.4.1. Drug Discovery & Development market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Toxicology & Pharmacokinetics Studies
5.5.1. Toxicology & Pharmacokinetics Studies market estimates and forecasts 2021 to 2033 (USD Million)
5.6. Basic & Translational Research
5.6.1. Basic & Translational Research market estimates and forecasts 2021 to 2033 (USD Million)
5.7. Disease Mechanism & Pathophysiology Studies
5.7.1. Disease Mechanism & Pathophysiology Studies market estimates and forecasts 2021 to 2033 (USD Million)
5.7.2. Oncology
5.7.2.1. Oncology market estimates and forecasts 2021 to 2033 (USD Million)
5.7.3. Cardiology
5.7.3.1. Cardiology market estimates and forecasts 2021 to 2033 (USD Million)
5.7.4. Neurology
5.7.4.1. Neurology market estimates and forecasts 2021 to 2033 (USD Million)
5.7.5. Infectious Diseases
5.7.5.1. Infectious Diseases market estimates and forecasts 2021 to 2033 (USD Million)
5.7.6. Immunology & Inflammation
5.7.6.1. Immunology & Inflammation market estimates and forecasts 2021 to 2033 (USD Million)
5.7.7. Others
5.7.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
5.8. Biomarker & Imaging Agent Validation
5.8.1. Biomarker & Imaging Agent Validation market estimates and forecasts 2021 to 2033 (USD Million)
5.9. Others
5.9.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Preclinical Imaging Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Preclinical Imaging End Use Market Movement Analysis
6.3. Global Preclinical Imaging Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
6.4. Pharma and Biotech Companies
6.4.1. Pharma and biotech companies market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Contract Research Organizations (CROs)
6.5.1. Contract Research Organizations (CROs) market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Academic and Research Institutes
6.6.1. Academic and Research Institutes market estimates and forecasts 2021 to 2033 (USD Million)
6.7. Others
6.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Preclinical Imaging Market: Regional Estimates & Trend Analysis By Type, Application, End Use
7.1. Regional Market Share Analysis, 2025 & 2033
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Competitive scenario
7.5.1.3. Regulatory framework
7.5.1.4. Reimbursement structure
7.5.1.5. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Regulatory framework
7.5.2.4. Reimbursement structure
7.5.2.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
7.5.3. Mexico
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Regulatory framework
7.5.3.4. Reimbursement structure
7.5.3.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Competitive scenario
7.6.1.3. Regulatory framework
7.6.1.4. Reimbursement structure
7.6.1.5. UK market estimates and forecasts 2021 to 2033 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement structure
7.6.2.5. Germany market estimates and forecasts 2021 to 2033 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory framework
7.6.3.4. Reimbursement structure
7.6.3.5. France market estimates and forecasts 2021 to 2033 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. Regulatory framework
7.6.4.4. Reimbursement structure
7.6.4.5. Italy market estimates and forecasts 2021 to 2033 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Regulatory framework
7.6.5.4. Reimbursement structure
7.6.5.5. Spain market estimates and forecasts 2021 to 2033 (USD Million)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. Regulatory framework
7.6.6.4. Reimbursement structure
7.6.6.5. Norway market estimates and forecasts 2021 to 2033 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Competitive scenario
7.6.7.3. Regulatory framework
7.6.7.4. Reimbursement structure
7.6.7.5. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Competitive scenario
7.6.8.3. Regulatory framework
7.6.8.4. Reimbursement structure
7.6.8.5. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Competitive scenario
7.7.1.3. Regulatory framework
7.7.1.4. Reimbursement structure
7.7.1.5. Japan market estimates and forecasts 2021 to 2033 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement structure
7.7.2.5. China market estimates and forecasts 2021 to 2033 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory framework
7.7.3.4. Reimbursement structure
7.7.3.5. India market estimates and forecasts 2021 to 2033 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Competitive scenario
7.7.4.3. Regulatory framework
7.7.4.4. Reimbursement structure
7.7.4.5. Australia market estimates and forecasts 2021 to 2033 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Competitive scenario
7.7.5.3. Regulatory framework
7.7.5.4. Reimbursement structure
7.7.5.5. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Competitive scenario
7.7.6.3. Regulatory framework
7.7.6.4. Reimbursement structure
7.7.6.5. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Competitive scenario
7.8.1.3. Regulatory framework
7.8.1.4. Reimbursement structure
7.8.1.5. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
7.8.2. Argentina
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Regulatory framework
7.8.2.4. Reimbursement structure
7.8.2.5. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Competitive scenario
7.9.1.3. Regulatory framework
7.9.1.4. Reimbursement structure
7.9.1.5. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Competitive scenario
7.9.2.3. Regulatory framework
7.9.2.4. Reimbursement structure
7.9.2.5. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Competitive scenario
7.9.3.3. Regulatory framework
7.9.3.4. Reimbursement structure
7.9.3.5. UAE market estimates and forecasts 2021 to 2033 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Competitive scenario
7.9.4.3. Regulatory framework
7.9.4.4. Reimbursement structure
7.9.4.5. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Key company market share analysis, 2025
8.4. Company Position Analysis
8.5. Company Categorization (Emerging Players, Innovators and Leaders)
8.6. Company Profiles
8.6.1. Cubresa Inc.
8.6.1.1. Company overview
8.6.1.2. Financial performance
8.6.1.3. Product benchmarking
8.6.1.4. Strategic initiatives
8.6.2. Bruker Corporation
8.6.2.1. Company overview
8.6.2.2. Financial performance
8.6.2.3. Product benchmarking
8.6.2.4. Strategic initiatives
8.6.3. Revvity (PerkinElmer, Inc)
8.6.3.1. Company overview
8.6.3.2. Financial performance
8.6.3.3. Product benchmarking
8.6.3.4. Strategic initiatives
8.6.4. FUJIFILM VisualSonics
8.6.4.1. Company overview
8.6.4.2. Financial performance
8.6.4.3. Product benchmarking
8.6.4.4. Strategic initiatives
8.6.5. Mediso Ltd.
8.6.5.1. Company overview
8.6.5.2. Financial performance
8.6.5.3. Product benchmarking
8.6.5.4. Strategic initiatives
8.6.6. Rigaku (MILabs B.V.)
8.6.6.1. Company overview
8.6.6.2. Financial performance
8.6.6.3. Product benchmarking
8.6.6.4. Strategic initiatives
8.6.7. MR Solutions
8.6.7.1. Company overview
8.6.7.2. Financial performance
8.6.7.3. Product benchmarking
8.6.7.4. Strategic initiatives
8.6.8. Aspect Imaging
8.6.8.1. Company overview
8.6.8.2. Financial performance
8.6.8.3. Product benchmarking
8.6.8.4. Strategic initiatives
8.6.9. TriFoil Imaging
8.6.9.1. Company overview
8.6.9.2. Financial performance
8.6.9.3. Product benchmarking
8.6.9.4. Strategic initiatives
8.6.10. Siemens Healthineers
8.6.10.1. Company overview
8.6.10.2. Financial performance
8.6.10.3. Product benchmarking
8.6.10.4. Strategic initiatives

List of Tables
Table 1 List of Abbreviation
Table 2 North America preclinical imaging market, By country, 2021 - 2033 (USD Million)
Table 3 North America preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 4 North America preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 5 North America preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 6 U.S. preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 7 U.S. preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 8 U.S. preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 9 Canada preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 10 Canada preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 11 Canada preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 12 Mexico preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 13 Mexico preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 14 Mexico preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 15 Europe preclinical imaging market, By country, 2021 - 2033 (USD Million)
Table 16 Europe preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 17 Europe preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 18 Europe preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 19 UK preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 20 UK preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 21 UK preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 22 Germany preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 23 Germany preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 24 Germany preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 25 France preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 26 France preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 27 France preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 28 Italy preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 29 Italy preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 30 Italy preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 31 Denmark preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 32 Denmark preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 33 Denmark preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 34 Sweden preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 35 Sweden preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 36 Sweden preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 37 Norway preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 38 Norway preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 39 Norway preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 40 Asia Pacific preclinical imaging market, By country, 2021 - 2033 (USD Million)
Table 41 Asia Pacific preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 42 Asia Pacific preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 43 Asia Pacific preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 44 Japan preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 45 Japan preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 46 Japan preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 47 China preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 48 China preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 49 China preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 50 India preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 51 India preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 52 India preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 53 Australia preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 54 Australia preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 55 Australia preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 56 South Korea preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 57 South Korea preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 58 South Korea preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 59 Thailand preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 60 Thailand preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 61 Thailand preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 62 Latin America preclinical imaging market, By Country, 2021 - 2033 (USD Million)
Table 63 Latin America preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 64 Latin America preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 65 Latin America preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 66 Brazil preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 67 Brazil preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 68 Brazil preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 69 Argentina preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 70 Argentina preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 71 Argentina preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 72 Middle East & Africa preclinical imaging market, By country, 2021 - 2033 (USD Million)
Table 73 Middle East & Africa preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 74 Middle East & Africa preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 75 Middle East & Africa preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 76 South Africa preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 77 South Africa preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 78 South Africa preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 79 Saudi Arabia preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 80 Saudi Arabia preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 81 Saudi Arabia preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 82 UAE preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 83 UAE preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 84 UAE preclinical imaging market, By end use, 2021 - 2033 (USD Million)
Table 85 Kuwait preclinical imaging market, By type, 2021 - 2033 (USD Million)
Table 86 Kuwait preclinical imaging market, By application, 2021 - 2033 (USD Million)
Table 87 Kuwait preclinical imaging market, By end use, 2021 - 2033 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Preclinical imaging market: Market outlook
Fig. 14 Preclinical imaging market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Preclinical imaging market driver impact
Fig. 20 Preclinical imaging restraint impact
Fig. 21 Preclinical imaging market: type movement analysis
Fig. 22 Preclinical imaging market: type outlook and key takeaways
Fig. 23 Modality market estimates and forecast, 2021 - 2033
Fig. 24 Optical Imaging (BLI & F) market estimates and forecast, 2021 - 2033
Fig. 25 MRI market estimates and forecast, 2021 - 2033
Fig. 26 PET market estimates and forecast, 2021 - 2033
Fig. 27 SPECT market estimates and forecast, 2021 - 2033
Fig. 28 CT market estimates and forecast, 2021 - 2033
Fig. 29 Ultrasound Imaging (US) market estimates and forecast, 2021 - 2033
Fig. 30 Photoacoustic Imaging (PAI) market estimates and forecast, 2021 - 2033
Fig. 31 Hybrid Imaging Systems market estimates and forecast, 2021 - 2033
Fig. 32 Bi-Modal market estimates and forecast, 2021 - 2033
Fig. 33 SPECT-CT market estimates and forecast, 2021 - 2033
Fig. 34 PET-CT market estimates and forecast, 2021 - 2033
Fig. 35 SPECT-PET market estimates and forecast, 2021 - 2033
Fig. 36 PET-MRI market estimates and forecast, 2021 - 2033
Fig. 37 Optical-CT market estimates and forecast, 2021 - 2033
Fig. 38 Others market estimates and forecast, 2021 - 2033
Fig. 39 Tri-Modal market estimates and forecast, 2021 - 2033
Fig. 40 PET-SPECT-CT market estimates and forecast, 2021 - 2033
Fig. 41 PET-SPECT-MRI market estimates and forecast, 2021 - 2033
Fig. 42 PET-CT-Optical market estimates and forecast, 2021 - 2033
Fig. 43 Others market estimates and forecast, 2021 - 2033
Fig. 44 Reagents market estimates and forecast, 2021 - 2033
Fig. 45 Services market estimates and forecast, 2021 - 2033
Fig. 46 Preclinical imaging market: application movement analysis
Fig. 47 Preclinical imaging market: application outlook and key takeaways
Fig. 48 Drug Discovery & Development market estimates and forecast, 2021 - 2033
Fig. 49 Toxicology & Pharmacokinetics Studies market estimates and forecast, 2021 - 2033
Fig. 50 Basic & Translational Research market estimates and forecast, 2021 - 2033
Fig. 51 Disease Mechanism & Pathophysiology Studies market estimates and forecast, 2021 - 2033
Fig. 52 Oncology market estimates and forecast, 2021 - 2033
Fig. 53 Cardiology market estimates and forecast, 2021 - 2033
Fig. 54 Neurology market estimates and forecast, 2021 - 2033
Fig. 55 Infectious Diseases market estimates and forecast, 2021 - 2033
Fig. 56 Immunology & Inflammation market estimates and forecast, 2021 - 2033
Fig. 57 Others market estimates and forecast, 2021 - 2033
Fig. 58 Biomarker & Imaging Agent Validation market estimates and forecast, 2021 - 2033
Fig. 59 Others market estimates and forecast, 2021 - 2033
Fig. 60 Preclinical imaging market: end use movement analysis
Fig. 61 Preclinical imaging market: end use outlook and key takeaways
Fig. 62 Pharma and biotech companies market estimates and forecast, 2021 - 2033
Fig. 63 Contract Research Organizations (CROs) market estimates and forecast, 2021 - 2033
Fig. 64 Academic and Research Institutes market estimates and forecast, 2021 - 2033
Fig. 65 Others market estimates and forecast, 2021 - 2033
Fig. 66 Global Preclinical Imaging Market: regional movement analysis
Fig. 67 Global Preclinical Imaging Market: regional outlook and key takeaways
Fig. 68 North America
Fig. 69 North America market estimates and forecast, 2021 - 2033
Fig. 70 U.S.
Fig. 71 U.S. market estimates and forecast, 2021 - 2033
Fig. 72 Canada
Fig. 73 Canada market estimates and forecast, 2021 - 2033
Fig. 74 Mexico
Fig. 75 Mexico market estimates and forecast, 2021 - 2033
Fig. 76 Europe
Fig. 77 Europe. market estimates and forecast, 2021 - 2033
Fig. 78 UK
Fig. 79 UK market estimates and forecast, 2021 - 2033
Fig. 80 Germany
Fig. 81 Germany market estimates and forecast, 2021 - 2033
Fig. 82 France
Fig. 83 France market estimates and forecast, 2021 - 2033
Fig. 84 Italy
Fig. 85 Italy market estimates and forecast, 2021 - 2033
Fig. 86 Spain
Fig. 87 Spain market estimates and forecast, 2021 - 2033
Fig. 88 Denmark
Fig. 89 Denmark market estimates and forecast, 2021 - 2033
Fig. 90 Sweden
Fig. 91 Sweden market estimates and forecast, 2021 - 2033
Fig. 92 Norway
Fig. 93 Norway market estimates and forecast, 2021 - 2033
Fig. 94 Asia Pacific
Fig. 95 Asia Pacific market estimates and forecast, 2021 - 2033
Fig. 96 Japan
Fig. 97 Japan market estimates and forecast, 2021 - 2033
Fig. 98 China
Fig. 99 China market estimates and forecast, 2021 - 2033
Fig. 100 India
Fig. 101 India market estimates and forecast, 2021 - 2033
Fig. 102 South Korea
Fig. 103 South Korea market estimates and forecast, 2021 - 2033
Fig. 104 Thailand
Fig. 105 Thailand market estimates and forecast, 2021 - 2033
Fig. 106 Australia
Fig. 107 Australia market estimates and forecast, 2021 - 2033
Fig. 108 Latin America
Fig. 109 Latin America market estimates and forecast, 2021 - 2033
Fig. 110 Brazil
Fig. 111 Brazil market estimates and forecast, 2021 - 2033
Fig. 112 Argentina
Fig. 113 Argentina market estimates and forecast, 2021 - 2033
Fig. 114 Middle East and Africa
Fig. 115 Middle East and Africa. market estimates and forecast, 2021 - 2033
Fig. 116 Saudi Arabia
Fig. 117 Saudi Arabia market estimates and forecast, 2021 - 2033
Fig. 118 South Africa
Fig. 119 South Africa market estimates and forecast, 2021 - 2033
Fig. 120 UAE
Fig. 121 UAE market estimates and forecast, 2021 - 2033
Fig. 122 Kuwait
Fig. 123 Kuwait market estimates and forecast, 2021 - 2033
Fig. 124 Participant categorization- Preclinical imaging market
Fig. 125 Market share of key market players- Preclinical imaging market